Canton Strategic Holdings (CNTN) Convertible Debt (2020 - 2021)
Canton Strategic Holdings (CNTN) posted Convertible Debt of $772899.0 for Q4 2021, down 39.94% on a QoQ basis from $1.3 million in Q4 2020, and down 39.94% year-over-year from $1.3 million in Q4 2020.
Canton Strategic Holdings (CNTN) Convertible Debt (2020 - 2021) Analysis & Trends
Canton Strategic Holdings' Convertible Debt history runs 2 years deep, the most recent figure standing at $772899.0 for Q4 2021.
- Quarterly Convertible Debt fell 39.94% year-over-year to $772899.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $772899.0 (down 39.94% YoY) and the FY2021 annual result came in at $772899.0, down 39.94% from the prior year.
- Convertible Debt was $772899.0 for Q4 2021 at Canton Strategic Holdings, down from $1.3 million in the prior quarter.
- Across five years, Convertible Debt topped out at $1.3 million in Q4 2020 and bottomed at $772899.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 772,899.00 |
| Dec 31, 2020 | 1.29 Mn |